EAGLE PHARMACEUTICALS INC's ticker is EGRX and the CUSIP is 269796108. A total of 179 filers reported holding EAGLE PHARMACEUTICALS INC in Q4 2019. The put-call ratio across all filers is 0.16 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $26 | +4.0% | 933 | 0.0% | 0.00% | – |
| Q4 2022 | $25 | -99.9% | 933 | 0.0% | 0.00% | – |
| Q3 2022 | $25,000 | -39.0% | 933 | 0.0% | 0.00% | – |
| Q2 2022 | $41,000 | +78.3% | 933 | +85.1% | 0.00% | – |
| Q1 2020 | $23,000 | -97.5% | 504 | -96.7% | 0.00% | -100.0% |
| Q4 2019 | $909,000 | +6.3% | 15,122 | 0.0% | 0.01% | 0.0% |
| Q3 2019 | $855,000 | +408.9% | 15,122 | +400.4% | 0.01% | +500.0% |
| Q2 2019 | $168,000 | -86.4% | 3,022 | -83.1% | 0.00% | -88.9% |
| Q3 2018 | $1,239,000 | – | 17,877 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tri Locum Partners LP | 94,922 | $4,063,000 | 1.33% |
| Smith, Graham & Co., Investment Advisors, LP | 277,572 | $11,880,000 | 1.05% |
| Krensavage Asset Management, LLC | 70,804 | $3,030,000 | 1.03% |
| BRANDES INVESTMENT PARTNERS, LP | 716,873 | $30,682,000 | 0.68% |
| GLOBEFLEX CAPITAL L P | 42,357 | $1,813,000 | 0.33% |
| Zebra Capital Management LLC | 6,472 | $277,000 | 0.32% |
| Capital Impact Advisors, LLC | 19,276 | $825,000 | 0.27% |
| Hein Park Capital Management LP | 31,977 | $1,369,000 | 0.26% |
| CHARTWELL INVESTMENT PARTNERS, LLC | 195,340 | $8,361,000 | 0.25% |
| Stanley-Laman Group, Ltd. | 24,000 | $1,027,000 | 0.15% |